D. Ricard, A. Idbaih, F. Ducray, M. Lahutte, K. Hoang-xuan et al., Primary brain tumours in adults, The Lancet, vol.379, issue.9830, pp.3791984-1996
DOI : 10.1016/S0140-6736(11)61346-9

A. Citri and Y. Yarden, EGF???ERBB signalling: towards the systems level, Nature Reviews Molecular Cell Biology, vol.96, issue.7, pp.505-516, 2006.
DOI : 10.1038/nrm1962

P. Huang, A. Xu, and F. White, Oncogenic EGFR Signaling Networks in Glioma, Science Signaling, vol.2, issue.87, p.6, 2009.
DOI : 10.1126/scisignal.287re6

S. Torp, S. Gulati, E. Johannessen, and A. Dalen, Coexpression of c-erbB 1?4 receptor proteins in human glioblastomas. An immunohistochemical study, J Exp Clin Cancer Res, vol.26, issue.3, pp.353-359, 2007.

J. Stommel, A. Kimmelman, H. Ying, R. Nabioullin, A. Ponugoti et al., Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies, Science, vol.318, issue.5848, pp.318287-290, 2007.
DOI : 10.1126/science.1142946

U. Andersson, D. Guo, B. Malmer, A. Bergenheim, T. Brannstrom et al., Epidermal growth factor receptor family (EGFR, ErbB2?4) in gliomas and meningiomas, Acta Neuropathologica, vol.108, issue.2, pp.135-142, 2004.
DOI : 10.1007/s00401-004-0875-6

D. Bhowmick, Z. Zhuang, S. Wait, and R. Weil, A Functional Polymorphism in the EGF Gene Is Found with Increased Frequency in Glioblastoma Multiforme Patients and Is Associated with More Aggressive Disease, Cancer Research, vol.64, issue.4, pp.1220-1223, 2004.
DOI : 10.1158/0008-5472.CAN-03-3137

A. Ekstrand, C. James, W. Cavenee, B. Seliger, R. Pettersson et al., Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo, Cancer Res, issue.8, pp.512164-2172, 1991.

K. Mishima, S. Higashiyama, A. Asai, K. Yamaoka, Y. Nagashima et al., Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas, Acta Neuropathologica, vol.96, issue.4, pp.322-328, 1998.
DOI : 10.1007/s004010050901

D. Ramnarain, S. Park, D. Lee, K. Hatanpaa, S. Scoggin et al., Differential Gene Expression Analysis Reveals Generation of an Autocrine Loop by a Mutant Epidermal Growth Factor Receptor in Glioma Cells, Cancer Research, vol.66, issue.2, pp.867-874, 2006.
DOI : 10.1158/0008-5472.CAN-05-2753

H. Toyoda, T. Komurasaki, D. Uchida, and S. Morimoto, Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family, Biochemical Journal, vol.326, issue.1, pp.32669-75, 1997.
DOI : 10.1042/bj3260069

M. Shelly, R. Pinkas-kramarski, B. Guarino, H. Waterman, L. Wang et al., Epiregulin Is a Potent Pan-ErbB Ligand That Preferentially Activates Heterodimeric Receptor Complexes, Journal of Biological Chemistry, vol.273, issue.17, pp.27310496-10505, 1998.
DOI : 10.1074/jbc.273.17.10496

T. Komurasaki, H. Toyoda, D. Uchida, and S. Morimoto, Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4, Oncogene, issue.23, pp.152841-2848, 1997.

H. Toyoda, T. Komurasaki, D. Uchida, Y. Takayama, T. Isobe et al., Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes, J Biol Chem, vol.270, issue.13, pp.7495-7500, 1995.

F. Revillion, V. Lhotellier, L. Hornez, J. Bonneterre, and J. Peyrat, ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis, Annals of Oncology, vol.19, issue.1, pp.73-80, 2008.
DOI : 10.1093/annonc/mdm431

Z. Zhu, J. Kleeff, H. Friess, L. Wang, A. Zimmermann et al., Epiregulin Is Up-Regulated in Pancreatic Cancer and Stimulates Pancreatic Cancer Cell Growth, Biochemical and Biophysical Research Communications, vol.273, issue.3, pp.1019-1024, 2000.
DOI : 10.1006/bbrc.2000.3033

V. Thogersen, B. Sorensen, S. Poulsen, T. Orntoft, H. Wolf et al., A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients, Cancer Res, issue.16, pp.616227-6233, 2001.

T. Watanabe, T. Kobunai, Y. Yamamoto, T. Kanazawa, T. Konishi et al., Prediction of liver metastasis after colorectal cancer using reverse transcription-polymerase chain reaction analysis of 10 genes, European Journal of Cancer, vol.46, issue.11, pp.462119-2126, 2010.
DOI : 10.1016/j.ejca.2010.04.019

B. Nicholson, H. Frierson, M. Conaway, J. Seraj, M. Harding et al., Profiling the Evolution of Human Metastatic Bladder Cancer, Cancer Research, vol.64, issue.21, pp.7813-7821, 2004.
DOI : 10.1158/0008-5472.CAN-04-0826

T. Hide, T. Takezaki, Y. Nakatani, H. Nakamura, J. Kuratsu et al., Combination of a Ptgs2 Inhibitor and an Epidermal Growth Factor Receptor-Signaling Inhibitor Prevents Tumorigenesis of Oligodendrocyte Lineage-Derived Glioma-Initiating Cells, STEM CELLS, vol.7, issue.part 3, pp.590-599, 2011.
DOI : 10.1002/stem.618

G. Auf, A. Jabouille, S. Guerit, R. Pineau, M. Delugin et al., Inositol-requiring enzyme 1?? is a key regulator of angiogenesis and invasion in malignant glioma, Proceedings of the National Academy of Sciences, vol.107, issue.35, pp.15553-15558, 2010.
DOI : 10.1073/pnas.0914072107

G. Gupta, D. Nguyen, A. Chiang, P. Bos, J. Kim et al., Mediators of vascular remodelling co-opted for sequential steps in lung metastasis, Nature, vol.59, issue.7137, pp.446765-770, 2007.
DOI : 10.1038/nature05760

K. Sasai, T. Akagi, E. Aoyanagi, K. Tabu, S. Kaneko et al., O6-methylguanine-DNA methyltransferase is downregulated in transformed astrocyte cells: implications for anti-glioma therapies, Molecular Cancer, vol.6, issue.1, p.36, 2007.
DOI : 10.1186/1476-4598-6-36

B. Drogat, M. Bouchecareilh, S. North, C. Petibois, G. Deleris et al., Acute L-glutamine deprivation compromises VEGF-a upregulation in A549/8 human carcinoma cells, Journal of Cellular Physiology, vol.17, issue.2, pp.463-472
DOI : 10.1002/jcp.21044

G. Lammering, K. Valerie, P. Lin, R. Mikkelsen, J. Contessa et al., Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor, Clin Cancer Res, vol.7, issue.3, pp.682-690, 2001.

K. Mishima, T. Johns, R. Luwor, A. Scott, E. Stockert et al., Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor, Cancer Res, issue.14, pp.615349-5354, 2001.

M. Hagedorn, S. Javerzat, D. Gilges, A. Meyre, B. De-lafarge et al., Accessing key steps of human tumor progression in vivo by using an avian embryo model, Proceedings of the National Academy of Sciences, vol.102, issue.5, pp.1643-1648, 2005.
DOI : 10.1073/pnas.0408622102

D. Acosta-alvear, Y. Zhou, A. Blais, M. Tsikitis, N. Lents et al., XBP1 Controls Diverse Cell Type- and Condition-Specific Transcriptional Regulatory Networks, Molecular Cell, vol.27, issue.1, pp.53-66, 2007.
DOI : 10.1016/j.molcel.2007.06.011

F. Urano, X. Wang, A. Bertolotti, Y. Zhang, P. Chung et al., Coupling of Stress in the ER to Activation of JNK Protein Kinases by Transmembrane Protein Kinase IRE1, Science, vol.287, issue.5453, pp.287664-666, 2000.
DOI : 10.1126/science.287.5453.664

Y. Shirakata, T. Komurasaki, H. Toyoda, Y. Hanakawa, K. Yamasaki et al., Epiregulin, a Novel Member of the Epidermal Growth Factor Family, Is an Autocrine Growth Factor in Normal Human Keratinocytes, Journal of Biological Chemistry, vol.275, issue.8, pp.2755748-5753, 2000.
DOI : 10.1074/jbc.275.8.5748

D. Taylor, X. Cheng, J. Pawlowski, A. Wallace, P. Ferrer et al., Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombin, Proceedings of the National Academy of Sciences, vol.96, issue.4, pp.1633-1638, 1999.
DOI : 10.1073/pnas.96.4.1633

D. Lee, R. Pearsall, S. Das, S. Dey, V. Godfrey et al., Epiregulin Is Not Essential for Development of Intestinal Tumors but Is Required for Protection from Intestinal Damage, Molecular and Cellular Biology, vol.24, issue.20, pp.248907-8916, 2004.
DOI : 10.1128/MCB.24.20.8907-8916.2004

M. Hsieh, D. Lee, S. Panigone, K. Horner, R. Chen et al., Luteinizing Hormone-Dependent Activation of the Epidermal Growth Factor Network Is Essential for Ovulation, Molecular and Cellular Biology, vol.27, issue.5, pp.1914-1924, 2007.
DOI : 10.1128/MCB.01919-06

H. Fan, Z. Liu, M. Shimada, E. Sterneck, P. Johnson et al., ERK1/2 in Ovarian Granulosa Cells Are Essential for Female Fertility., Biology of Reproduction, vol.81, issue.Suppl_1, pp.324938-941, 2009.
DOI : 10.1093/biolreprod/81.s1.153

S. Shirasawa, S. Sugiyama, I. Baba, J. Inokuchi, S. Sekine et al., Dermatitis due to epiregulin deficiency and a critical role of epiregulin in immune-related responses of keratinocyte and macrophage, Proceedings of the National Academy of Sciences, vol.101, issue.38, pp.13921-13926, 2004.
DOI : 10.1073/pnas.0404217101

L. Regales, Y. Gong, R. Shen, E. De-stanchina, I. Vivanco et al., Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer, Journal of Clinical Investigation, issue.10, pp.1193000-3010, 2009.
DOI : 10.1172/JCI38746DS1

L. Sauer, D. Gitenay, C. Vo, and V. Baron, Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells, Oncogene, vol.3, issue.18, pp.292628-2637, 2010.
DOI : 10.1038/sj.cdd.4402029

M. Cho, H. Choi, S. Lee, B. Kim, M. Jung et al., Epiregulin expression by Ets-1 and ERK signaling pathway in Ki-ras-transformed cells, Biochemical and Biophysical Research Communications, vol.377, issue.3, pp.832-837, 2008.
DOI : 10.1016/j.bbrc.2008.10.053

H. Kim, M. Kim, A. Hancock, J. Harper, J. Park et al., Identification of Novel Wilms' Tumor Suppressor Gene Target Genes Implicated in Kidney Development, Journal of Biological Chemistry, vol.282, issue.22, pp.28216278-16287
DOI : 10.1074/jbc.M700215200

T. Hayashida, F. Takahashi, N. Chiba, E. Brachtel, M. Takahashi et al., HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis, Proceedings of the National Academy of Sciences, vol.107, issue.3, pp.1100-1105, 2010.
DOI : 10.1073/pnas.0912710107

F. Orso, E. Penna, D. Cimino, E. Astanina, F. Maione et al., AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs, FASEB J, issue.8, pp.222702-2714, 2008.

X. Li, P. Massa, A. Hanidu, G. Peet, P. Aro et al., IKKalpha , IKKbeta , and NEMO/IKKgamma Are Each Required for the NF-kappa B-mediated Inflammatory Response Program, Journal of Biological Chemistry, vol.277, issue.47, pp.27745129-45140, 2002.
DOI : 10.1074/jbc.M205165200

C. Charalambous, A. Hannigan, P. Tsimbouri, G. Mcphee, and J. Wilson, Latent membrane protein 1-induced EGFR signalling is negatively regulated by TGF?? prior to neoplasia, Carcinogenesis, vol.28, issue.8, pp.1839-1848, 2007.
DOI : 10.1093/carcin/bgm055

E. Pereira, N. Liao, G. Neale, and L. Hendershot, Transcriptional and Post-Transcriptional Regulation of Proangiogenic Factors by the Unfolded Protein Response, PLoS ONE, vol.57, issue.9, p.12521, 2010.
DOI : 10.1371/journal.pone.0012521.s008

C. Sloss, F. Wang, M. Palladino, J. Cusack, and . Jr, Abstract A74: Activation of EGFR by proteasome inhibition requires HB-EGF in pancreatic cancer cells, Molecular Cancer Therapeutics, vol.8, issue.Supplement 1, pp.293146-3152, 2010.
DOI : 10.1158/1535-7163.TARG-09-A74

W. Ding, H. Ni, W. Gao, T. Yoshimori, D. Stolz et al., Linking of Autophagy to Ubiquitin-Proteasome System Is Important for the Regulation of Endoplasmic Reticulum Stress and Cell Viability, The American Journal of Pathology, vol.171, issue.2, pp.513-524, 2007.
DOI : 10.2353/ajpath.2007.070188

H. Kato, S. Nakajima, Y. Saito, S. Takahashi, R. Katoh et al., mTORC1 serves ER stress-triggered apoptosis via selective activation of the IRE1???JNK pathway, Cell Death and Differentiation, vol.176, issue.2, pp.1310-320
DOI : 10.1016/j.bbrc.2009.08.070

E. Hoffmann, J. Ashouri, S. Wolter, A. Doerrie, O. Dittrich-breiholz et al., Transcriptional regulation of EGR-1 by the interleukin-1-JNK-MKK7-c-Jun pathway, J Biol Chem, issue.18, pp.28312120-12128, 2008.

P. Menu, A. Mayor, R. Zhou, A. Tardivel, H. Ichijo et al., ER stress activates the NLRP3 inflammasome via an UPR-independent pathway, Cell Death and Disease, vol.26, issue.1, p.261, 2012.
DOI : 10.1038/cddis.2011.132

G. Smith and C. Strunz, Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes, Glia, vol.109, issue.3, pp.209-218, 2005.
DOI : 10.1002/glia.20236

. Auf, High epiregulin expression in human U87 glioma cells relies on IRE1?? and promotes autocrine growth through EGF receptor, BMC Cancer, vol.52, issue.3, p.597, 2013.
DOI : 10.1002/glia.20236
URL : https://hal.archives-ouvertes.fr/inserm-00922900